These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 19038502)

  • 21. Diabesity: palliating, curing or preventing the dysmetabolic diathesis.
    Kral JG
    Maturitas; 2014 Mar; 77(3):243-8. PubMed ID: 24439056
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A review for clinicians: Prostate cancer and the antineoplastic properties of metformin.
    Hankinson SJ; Fam M; Patel NN
    Urol Oncol; 2017 Jan; 35(1):21-29. PubMed ID: 27836248
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Managing the side effects of androgen-deprivation therapy.
    J Support Oncol; 2007 Feb; 5(2):87-8. PubMed ID: 17348368
    [No Abstract]   [Full Text] [Related]  

  • 24. [Management of the side effects of androgenic deprivation].
    Lebret T; Méjean A
    Prog Urol; 2008 Nov; 18 Suppl 7():S338-42. PubMed ID: 19070813
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiovascular and metabolic complications during androgen deprivation: exercise as a potential countermeasure.
    Galvão DA; Taaffe DR; Spry N; Joseph D; Newton RU
    Prostate Cancer Prostatic Dis; 2009; 12(3):233-40. PubMed ID: 19488067
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment of lipid disorders in metabolic syndrome and type 2 diabetes. The place for fibrates].
    Cybulska B; Kłosiewicz-Latoszek L
    Kardiol Pol; 2005 Jun; 62 Suppl 2():II45-50. PubMed ID: 19813336
    [No Abstract]   [Full Text] [Related]  

  • 27. Complications of androgen deprivation therapy in prostate cancer.
    Schwandt A; Garcia JA
    Curr Opin Urol; 2009 May; 19(3):322-6. PubMed ID: 19318949
    [TBL] [Abstract][Full Text] [Related]  

  • 28. What effect does androgen suppression therapy have on frequency and timing of fatal myocardial infarctions?
    Holzbeierlein JM
    Nat Clin Pract Oncol; 2008 Feb; 5(2):74-5. PubMed ID: 17971802
    [No Abstract]   [Full Text] [Related]  

  • 29. Estradiol and cognition during androgen deprivation in men with prostate carcinoma.
    Wassersug RJ; Wadhwa D
    Cancer; 2005 Nov; 104(9):2032-3; author reply 2033. PubMed ID: 16196043
    [No Abstract]   [Full Text] [Related]  

  • 30. Obesity and metabolic disease.
    Koopman RJ; Swofford SJ; Beard MN; Meadows SE
    Prim Care; 2009 Jun; 36(2):257-70. PubMed ID: 19501242
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Androgen deprivation therapy and prostate cancer duration.
    Williams SG; Pickles T; Buyyounouski MK
    J Clin Oncol; 2009 Dec; 27(34):e228; author reply e229. PubMed ID: 19884533
    [No Abstract]   [Full Text] [Related]  

  • 32. Diabetes--asking the right questions.
    Hyman MA
    Altern Ther Health Med; 2006; 12(5):10-3. PubMed ID: 17017750
    [No Abstract]   [Full Text] [Related]  

  • 33. [Physical activity and chronic disease II. Type 2 diabetes, obesity and cancer].
    Magnusson P; Torp-Pedersen CT; Backer V; Beyer N; Andersen LB; Hansen IL; Dela F; Astrup AV; Pedersen BK; Tjønneland AM; Schwarz P; Kjaer M
    Ugeskr Laeger; 2004 Apr; 166(17):1547-51. PubMed ID: 15146685
    [No Abstract]   [Full Text] [Related]  

  • 34. The metabolic syndrome: in need of a global mission statement.
    Cameron AJ; Zimmet PZ; Shaw JE; Alberti KG
    Diabet Med; 2009 Mar; 26(3):306-9. PubMed ID: 19317827
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insulin resistance syndrome and glucose dysregulation in the elderly.
    Mazza AD
    Clin Geriatr Med; 2008 Aug; 24(3):437-54, vi. PubMed ID: 18672181
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Does prophylactic breast irradiation in patients with prostate cancer influence cardiac toxicity?
    Nieder C; Pawinski A; Andratschke NH; Molls M
    J Natl Cancer Inst; 2007 Nov; 99(21):1646-7. PubMed ID: 17971531
    [No Abstract]   [Full Text] [Related]  

  • 37. Case-based study: from prediabetes to complications--opportunities for prevention.
    Rappaport J; Fonseca V
    PLoS Med; 2005 Feb; 2(2):e40. PubMed ID: 15736996
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Prevention of type 2 diabetes: "We need preventive measures". Interview by Rüdiger Meyer].
    Hauner H
    Dtsch Med Wochenschr; 2005 Oct; Suppl 1():83. PubMed ID: 16379252
    [No Abstract]   [Full Text] [Related]  

  • 39. "Staging the aging" when considering androgen deprivation therapy for older men with prostate cancer.
    Dale W
    J Clin Oncol; 2009 Jul; 27(21):3420-2. PubMed ID: 19506150
    [No Abstract]   [Full Text] [Related]  

  • 40. [New knowledge of the cause of diabetes?].
    Vaag AA; Eldrup E; Borch-Johsen K; Gaede PH; Pedersen OB
    Ugeskr Laeger; 2001 Jul; 163(27):3812-6. PubMed ID: 11466994
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.